Robert Fenstermaker, MD
Robert Fenstermaker, MD
Professor of Neurosurgery and Oncology
Chair, Department of Neurosurgery
Director, Neuro-Oncology Program
Roswell Park Comprehensive Cancer Center
Department of Neurosurgery
Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
Is this your physician?
Or call 1-800-ROSWELL
Areas of Expertise:
Brain Tumor Surgery
Skull Base Surgery
Pituitary Tumor Surgery
Trigeminal Neuralgia
Gamma Knife Radiosurgery
Special Interests:
Immunotherapy for the treatment of malignant brain tumors
Background
Education and Training:
MD - Northeast Ohio Medical University, Rootstown, OH
Residency:
University Hospitals of Cleveland and Case Western Reserve University School of Medicine, Cleveland, OH
Fellowship:
Case Western Reserve University School of Medicine (Biochemistry and Pharmacology) Cleveland, OH
Board Certification:
Neurological Surgery, American Board of Neurological Surgery
- Galbo P, Ciesielski MJ, Figel S, Maguire O, Qiu J, Wiltsie L, Minderman H, Fenstermaker RA. Circulating CD9+/GFAP+/survivin+ exosomes in malignant glioma patients following survivin vaccination. Oncotarget, in press
- Winograd EK, Ciesielski MJ, Fenstermaker RA. Novel vaccines for glioblastoma: clinical update and perspective. Immunotherapy. 2016 Nov;8(11):1293-1308.
- Fenstermaker RA, Ciesielski MJ, Qiu J, Yang N, Frank CL, Lee KP, Mechtler LR, Belal A, Ahluwalia MS, Hutson AD. Clinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma. Cancer Immunol Immunother. 2016 Nov;65(11):1339-1352. Epub 2016 Aug 30.
- Fenstermaker R, Abad A. Imaging of Pituitary and Parasellar Disorders. Continuum (Minneap Minn). 2016 Oct;22(5, Neuroimaging):1574-1594.
- Nabors LB, Portnow J, Ammirati M, Baehring J, Brem H, Brown P, Butowski N, Chamberlain MC, Fenstermaker RA, Friedman A, Gilbert MR, Hattangadi-Gluth J, Holdhoff M, Junck L, Kaley T, Lawson R, Loeffler JS, Lovely MP, Moots PL, Mrugala MM, Newton HB, Parney I, Raizer JJ, Recht L, Shonka N, Shrieve DC, Sills AK Jr, Swinnen LJ, Tran D, Tran N, Vrionis FD, Weiss S, Wen PY, McMillian N, Engh AM. Central Nervous System Cancers, Version 1.2015. J Natl Compr Canc Netw. 2015 Oct;13(10):1191-202.
- Shen L, Sundstedt A, Ciesielski M, Miles KM, Celander M, Adelaiye R, Orillion A, Ciamporcero E, Ramakrishnan S, Ellis L, Fenstermaker R, Abrams SI, Eriksson H, Leanderson T, Olsson A, Pili R. Tasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine models. Cancer Immunol Res. 2015 Feb;3(2):136-48.
- Kusner LL, Ciesielski MJ, Marx A, Kaminski HJ, Fenstermaker RA. Survivin as a potential mediator to support autoreactive cell survival in myasthenia gravis: a human and animal model study. PLoS One. 2014 Jul 22;9(7):e102231.
- Fenstermaker RA, Ciesielski MJ. Challenges in the development of a survivin vaccine (SurVaxM) for malignant glioma. Expert Rev Vaccines. 2014 Mar;13(3):377-85.
- Munich SA, Fenstermaker RA, Fabiano AJ, Rigual NR. Cranial base repair with combined vascularized nasal septal flap and autologous tissue graft following expanded endonasal endoscopic neurosurgery. J Neurol Surg A Cent Eur Neurosurg. 2013 Mar;74(2):101-8.
- Gruber TJ, Fabiano AJ, Deeb G, Lele SB, Fenstermaker RA. Intracranial meningiomas in patients with uterine sarcoma treated with long-term megestrol acetate therapy. World Neurosurg. 2011 Nov;76(5):477.e16-20.
Is this your physician?
Or call 1-800-ROSWELL